News

Laxxon Medical to Attend 42nd Annual J.P. Morgan Healthcare Conference in San Francisco

NEW YORK, NY / ACCESSWIRE / December 6, 2023 / Laxxon Medical announced today its attendance at the 42nd Annual…

2 years ago

ZyVersa Therapeutics Announces Publication Showing AIM2 and NLRP3 Inflammasomes Promote Atherosclerosis in Diabetes, Supporting IC 100’s Rationale for Targeting ASC to Inhibit Multiple Inflammasome Pathways

Atherosclerosis, an inflammatory disease characterized by buildup of cholesterol, lipids, and other substances (plaque) in arteries leading to heart attack…

2 years ago

Kraig Biocraft Laboratories Prepares for Silk Production Season

ANN ARBOR, Mich., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the…

2 years ago

Pharvaris Announces Pricing of $300 Million Underwritten Offering of Ordinary Shares and Pre-funded Warrants

ZUG, Switzerland, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris”, Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin…

2 years ago

First Wave BioPharma to Participate in BIO Partnering @JPM During “J.P. Morgan Week 2024” 

BOCA RATON, Fla., Dec. 06, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ: FWBI) (“First Wave BioPharma” or the…

2 years ago

Four E’s Scientific Partners With Bioz to Empower Researchers With the Integration of Bioz Badges

PALO ALTO, CA / ACCESSWIRE / December 6, 2023 / Bioz, Inc., a leading AI software company based in Silicon…

2 years ago

Rare Element Resources Announces Intent to Launch Rights Offering of Common Shares

Proceeds Planned to Advance the Bear Lodge Rare Earth ProjectLITTLETON, Colo.--(BUSINESS WIRE)--Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB:…

2 years ago

Delota Corp. Announces $900,000 Convertible Debenture Unit Offering

Vaughan, Ontario--(Newsfile Corp. - December 5, 2023) - Delota Corp. (CSE: LOTA) ("Delota" or the "Company"), is excited to announce…

2 years ago

Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes

WINNIPEG, MB / ACCESSWIRE / December 5, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused…

2 years ago